एपीए उद्धरण

Shoukry, H. S., Ammar, H. I., Rashed, L. A., Zikri, M. B., Shamaa, A. A., Abou elfadl, S. G., . . . Dhingra, S. (2017). Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity. PLoS One.

शिकागो स्टाइल उद्धरण

Shoukry, Heba Samy, Hania Ibrahim Ammar, Laila Ahmed Rashed, Maha Balegh Zikri, Ashraf Ali Shamaa, Sahar Gamal Abou elfadl, Ejlal Abu-Al Rub, Sekaran Saravanan, और Sanjiv Dhingra. "Prophylactic Supplementation of Resveratrol Is More Effective Than Its Therapeutic Use against Doxorubicin Induced Cardiotoxicity." PLoS One 2017.

एमएलए उद्धरण

Shoukry, Heba Samy, et al. "Prophylactic Supplementation of Resveratrol Is More Effective Than Its Therapeutic Use against Doxorubicin Induced Cardiotoxicity." PLoS One 2017.